Suraksha Diagnostic Limited — Board Meeting, 28-05-2025: Outcome of Board Meeting

Suraksha Diagnostic Limited has announced a board meeting that approved audited consolidated financial results for the quarter and financial year ended March 31, 2025. Revenue climbed to ₹252.09 Cr from ₹216.71 Cr last year, while PAT surged to ₹30.98 Cr versus ₹23.13 Cr. EPS hit ₹5.97. The board set the 20th AGM date and reappointed auditors for secretarial, internal, and cost audits. Post-year-end, Suraksha expanded its presence by acquiring Fetomat Wellness Pvt Ltd as a subsidiary.